U.S. Intrauterine Devices Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The U.S. Intrauterine Devices (IUDs) Market was valued at USD 1.4 billion in 2023 and is projected to expand at 9.5% CAGR from 2024 to 2032.

Technological advancements and ongoing research are enhancing the safety, effectiveness, and user experience of IUDs in the country. The focus of R&D is prolonging the effectiveness of hormonal IUDs. The newest IUDs provide protection for up to 7 years, an upgrade from the previous 3-5 year standard. Furthermore, some of these advanced hormonal IUDs feature adjustable hormone release levels, addressing individual needs and reducing side effects. Such customization proves beneficial in managing conditions like heavy menstrual bleeding.

The U.S. intrauterine devices market is segmented into product, age group, end-use, and region.

In terms of product, the market divides into copper IUDs and hormonal IUDs. Dominating the market, the hormonal IUD segment generated approximately USD 1.1 billion in revenue in 2023. Beyond contraception, hormonal IUDs offer non-contraceptive health benefits, including relief from chronic pelvic pain, management of polycystic ovary syndrome (PCOS) symptoms, and hormone replacement therapy for perimenopausal women. Surveys highlight that women favor hormonal IUDs not just for their efficacy but also for the reduced menstrual side effects and added health benefits.

End-use categories for the U.S. intrauterine devices market include hospitals, gynecology clinics, and community health care centers. Hospitals led the market with a revenue share of about 49% in 2023. Offering integrated care, hospitals enable patients to access consultations, diagnostic tests, and IUD insertion procedures all under one roof. This holistic approach draws more patients seeking contraceptive solutions. Moreover, with a broader patient base than smaller clinics or community centers, hospitals naturally see a higher volume of IUD insertions.

In 2023, the South Atlantic U.S. intrauterine devices market generated USD 275.5 million in revenue and is set for significant growth by 2032. Densely populated urban centers like Miami, Atlanta, and Charlotte will drive the demand for contraceptive options, including IUDs. Furthermore, local health departments and non-profit organizations play a pivotal role, actively promoting family planning and contraceptive awareness. Their educational campaigns on the benefits and safety of IUDs may significantly boost product adoption.

Product Code: 2895

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Favorable regulatory scenario
  - 3.2.1.2 Rising awareness among women regarding various IUD applications
  - 3.2.1.3 High number of unintended pregnancies
  - 3.2.1.4 Government initiatives for the prevention of unwanted abortions and pregnancies
  - 3.2.1.5 Growing inclination towards planned delayed pregnancy
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of device
  - 3.2.2.2 Risk of several health issues
  - 3.2.2.3 Variability in insurance coverage and access
3.3 Growth potential analysis
3.4 Technology landscape
3.5 U.S. intrauterine device units sold, by brand, 2021 -2032
3.6 Future market trends
3.7 Regulatory landscape
3.8 Reimbursement scenario
3.9 Gap analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Company market share analysis
4.5 Company positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Copper IUD
5.3 Hormonal IUD

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 15-19
6.3 20-24
6.4 25-29
6.5 30-34
6.6 35-39
6.7 40-44
6.8 45+

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Gynecology clinics
7.4 Community health care centers

Chapter 8 Market Estimates and Forecast, By Zone, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 East North Central
- 8.2.1 Illinois
- 8.2.2 Indiana
- 8.2.3 Michigan
- 8.2.4 Ohio
- 8.2.5 Wisconsin
8.3 West South Central
- 8.3.1 Arkansas
- 8.3.2 Louisiana
- 8.3.3 Oklahoma
- 8.3.4 Texas
8.4 South Atlantic
- 8.4.1 Delaware
- 8.4.2 Florida
- 8.4.3 Georgia
- 8.4.4 Maryland
- 8.4.5 North Carolina
- 8.4.6 South Carolina
- 8.4.7 Virginia
- 8.4.8 West Virginia
- 8.4.9 Washington, D.C.
8.5 Northeast
- 8.5.1 Connecticut
- 8.5.2 Maine
- 8.5.3 Massachusetts
- 8.5.4 New Hampshire
- 8.5.5 Rhode Island
- 8.5.6 Vermont
- 8.5.7 New Jersey
- 8.5.8 New York
- 8.5.9 Pennsylvania
8.6 East South Central
- 8.6.1 Alabama
- 8.6.2 Kentucky
- 8.6.3 Mississippi
- 8.6.4 Tennessee
8.7 West North Central
- 8.7.1 Iowa
- 8.7.2 Kansas
- 8.7.3 Minnesota
- 8.7.4 Missouri
- 8.7.5 Nebraska
- 8.7.6 North Dakota
- 8.7.7 South Dakota
8.8 Pacific Central
- 8.8.1 Alaska
- 8.8.2 California
- 8.8.3 Hawaii
- 8.8.4 Oregon
- 8.8.5 Washington
8.9 Mountain States
- 8.9.1 Arizona
- 8.9.2 Colorado
- 8.9.3 Utah
- 8.9.4 Nevada
- 8.9.5 New Mexico
- 8.9.6 Idaho
- 8.9.7 Montana
- 8.9.8 Wyoming

Chapter 9 Company Profiles

9.1 Allergan (AbbVie Inc.)
9.2 Bayer AG
9.3 CooperSurgical Inc.
9.4 Durbin
9.5 Meril Life Sciences Pvt. Ltd.
9.6 Mylan N.V. (Viatris)
9.7 Pregna International Ltd.
9.8 SMB Corporation of India